Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

Similar articles for PubMed (Select 20615303)

1.

Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international survey.

Rogers BA, Phillips S, Foote J, Drabu KJ.

Ann R Coll Surg Engl. 2010 Nov;92(8):668-72. doi: 10.1308/003588410X12699663904952. Epub 2010 Jul 2.

2.

Patient evaluation of outpatient venous thromboembolism prophylaxis service following lower limb injuries using a developed validated questionnaire.

Menakaya CU, Khan AS, Nunn T, Pennington N, Ward M, Malhotra R, Muthukumar N, Mohsen A.

J Perioper Pract. 2015 Apr;25(4):72-7.

PMID:
26012185
3.

Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.

Asopa V, Cobain W, Martin D, Keene G, Bauze A.

ANZ J Surg. 2015 May 21. doi: 10.1111/ans.13174. [Epub ahead of print]

PMID:
25997601
4.

Real-world data confirm clinical trial outcomes for rivaroxaban in orthopaedic patients.

Kwong L, Turpie AG.

Curr Orthop Pract. 2015 May;26(3):299-305. Review.

5.

Dabigatran etexilate and LMWH for the prevention of venous thromboembolism in 532 patients undergoing hip surgery.

Bonarelli S, Bacchin MR, Frugiuele I, Feoli MA, Facchini F, Altimari V.

Eur Rev Med Pharmacol Sci. 2015;19(5):897-903.

6.

Venous thromboembolism (VTE) prophylaxis and urological pelvic cancer surgery: a UK national audit.

Pridgeon S, Allchorne P, Turner B, Peters J, Green J.

BJU Int. 2015 Feb;115(2):223-9.

PMID:
25756135
7.

Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty.

Charters MA, Frisch NB, Wessell NM, Dobson C, Les CM, Silverton CD.

J Arthroplasty. 2015 Jul;30(7):1277-80. doi: 10.1016/j.arth.2015.02.009. Epub 2015 Feb 17.

PMID:
25724111
8.

Decision making in venous thromboembolism prophylaxis: Is LWMH being inappropriately withheld from patients admitted with chronic liver disease?

Lau C, Burd C, Abeles D, Sherman D.

Clin Med. 2015 Feb;15(1):31-4. doi: 10.7861/clinmedicine.15-1-31.

PMID:
25650195
9.

Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit.

Dixon J, Ahn E, Zhou L, Lim R, Simpson D, Merriman EG.

Intern Med J. 2015 Apr;45(4):416-22. doi: 10.1111/imj.12702.

PMID:
25644232
10.

Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A; American Society of Clinical Oncology.

J Clin Oncol. 2015 Feb 20;33(6):654-6. doi: 10.1200/JCO.2014.59.7351. Epub 2015 Jan 20.

PMID:
25605844
11.

[Aspects of the practical application of direct oral anticoagulants in traumatological and orthopedic hospital].

Bozhkova SA, Novokshonova AA, Drozdova PV.

Khirurgiia (Mosk). 2014;(11):48-54. Russian. No abstract available.

PMID:
25589184
12.

The effect of clinical decision support on adherence to thrombosis prophylaxis guidelines in medical patients; a single center experience.

Eijgenraam P, Meertens N, van den Ham R, Ten Cate H, Ten Cate-Hoek AJ.

Thromb Res. 2015 Mar;135(3):464-71. doi: 10.1016/j.thromres.2014.12.012. Epub 2014 Dec 13.

PMID:
25538031
13.

Hip International in 2015.

Spencer RF, Learmonth ID.

Hip Int. 2014 Dec 5;24(6):555. doi: 10.5301/hipint.5000212. Epub 2014 Nov 20. No abstract available.

14.

Preoperative dosing of low-molecular-weight heparin in hepatopancreatobiliary surgery.

Doughtie CA, Priddy EE, Philips P, Martin RC, McMasters KM, Scoggins CR.

Am J Surg. 2014 Dec;208(6):1009-15; discussion 1015. doi: 10.1016/j.amjsurg.2014.08.012. Epub 2014 Sep 28.

PMID:
25435300
15.

A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns.

Molinari AC, Banov L, Bertamino M, Barabino P, Lassandro G, Giordano P.

Pediatr Hematol Oncol. 2015 Feb;32(1):1-10. doi: 10.3109/08880018.2014.960119. Epub 2014 Oct 17.

PMID:
25325764
16.

A survey to establish current methods of venous thromboembolism prophylaxis in stroke patients practiced by Polish neurologists.

Bembenek JP, Dennis M, Czlonkowska A.

Arch Med Sci. 2014 Jun 29;10(3):470-6. doi: 10.5114/aoms.2014.43742. Epub 2014 Jun 27.

17.

Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study.

Lazo-Langner A, Fleet JL, McArthur E, Garg AX.

J Thromb Haemost. 2014 Oct;12(10):1626-35. doi: 10.1111/jth.12675. Epub 2014 Aug 26.

PMID:
25069387
18.

A survey of the current state of hip arthroplasty surveillance in the United kingdom.

Smith LK.

Musculoskeletal Care. 2014 Dec;12(4):232-8. doi: 10.1002/msc.1077. Epub 2014 Jul 28. No abstract available.

PMID:
25065760
19.

Venous thromboembolism prophylaxis guideline compliance: a pilot study of augmented medication charts.

Cunningham R, Murray A, S Byrne J, Hammond L, Barry M, Mehigan D, Sheehan S.

Ir J Med Sci. 2015 Jun;184(2):469-74. doi: 10.1007/s11845-014-1148-6. Epub 2014 Jul 15.

PMID:
25023126
20.

High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline.

Leijtens B, Kremers van de Hei K, Jansen J, Ko√ęter S.

Arch Orthop Trauma Surg. 2014 Sep;134(9):1335-41. doi: 10.1007/s00402-014-2034-4. Epub 2014 Jul 3.

PMID:
24990654
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk